Technology
Health
Medical

Cardiovascular Systems

$39.54
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.33 (0.84%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell CSII and other stocks, options, ETFs, and crypto commission-free!

About

Cardiovascular Systems, Inc. Common Stock, also called Cardiovascular Systems, is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. Read More It offers orbital atherectomy systems for both peripheral and coronary commercial applications. Its products are catheter-based platforms capable of treating a range of vessel sizes and plaque types. The company was founded in 2000 and is headquartered in St. Paul, MN.

Employees
652
Headquarters
St. Paul, Minnesota
Founded
2000
Market Cap
1.38B
Price-Earnings Ratio
687.65
Dividend Yield
0.00
Average Volume
338.19K
High Today
$39.98
Low Today
$38.58
Open Price
$38.91
Volume
111.47K
52 Week High
$42.64
52 Week Low
$24.84

Collections

Technology
Health
Medical
Water Transportation
Transportation
US
North America

News

NasdaqMay 2

Cardiovascular Systems (CSII) Q3 Earnings Top, View Tapered

Cardiovascular Systems, Inc. CSII delivered earnings per share of 2 cents in third-quarter fiscal 2019 compared with the year-ago earnings of a penny. The reported figure beat the Zacks Consensus Estimate of a loss of 4 cents. Net Sales Cardiovascular Systems' revenues of $63.3 million in the fiscal third quarter marks a 13.9% year-over-year increase. Meanwhile, the top line matched the Zacks Consensus Estimate. Segment Details Coronary device revenues jumped above 24% year over year to $18.2 million. ...

15
Seeking AlphaMay 1

Cardiovascular Systems' (CSII) CEO Scott Ward on Q3 2019 Results - Earnings Call Transcript

Cardiovascular Systems, Inc. (NASDAQ:CSII) Q3 2019 Earnings Conference Call May 1, 2019 4:30 PM ET Company Participants Jack Nielsen – Vice President, Investor Relations and Corporate Communications Scott Ward – Chairman, President and Chief Executive Officer Jeff Points – Chief Financial Officer Rhonda Robb – Chief Operating Officer Conference Call Participants Mathew Blackman – Stifel Danielle Antalffy – SVB Leerink David Saxon – Needham & Company Brooks O’Neil – Lake Street Capital Brandon Vaz...

5
Yahoo FinanceMay 1

Cardiovascular Systems, Inc. Reports Fiscal 2019 Third-Quarter Financial Results

ST. PAUL, Minn.--(BUSINESS WIRE)-- Conference Call Scheduled for Today, May 1, 2019, at 3:30 PM CT (4:30 PM ET) Cardiovascular Systems, Inc. (CSI®) (CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today reported financial results for its fiscal third quarter, ended March 31, 2019. CSI’s third-quarter revenues were $63.3 million, an increase of $7.7 million, or 13.9%, from the third quarter...

3

Earnings

-$0.09
-$0.02
$0.04
$0.11
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
Actual
Expected Jul 31, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.